MYC and Chronic colitis: Using both the DSS-induced chronic colitis model and the AOM/DSS-induced CAC model, we demonstrated that CU06-1004 exerts its biological effects via a multifaceted mechanism by attenuating immune cell infiltration, downregulating pro-inflammatory cytokines, and inhibiting oncogenic β-catenin/c-Myc signaling (Figure 7).